Shaun C Williams
Affiliation: Woolcock Institute of Medical Research
- The effect of modafinil following acute CPAP withdrawal: a preliminary studyShaun C Williams
Sleep and Circadian Research Group, Woolcock Institute of Medical Research, Sydney, Australia
Sleep Breath 12:359-64. 2008..04) compared to placebo. These data do not support the use of modafinil for the maintenance of daytime functioning in patients with OSA who are acutely withdrawn from CPAP...
- Modafinil effects during acute continuous positive airway pressure withdrawal: a randomized crossover double-blind placebo-controlled trialShaun C Williams
Sleep and Circadian Research Group NHMRC Centre for Sleep Medicine, Woolcock Institute, University of Sydney and Royal Prince Alfred Hospital, Sydney, Australia
Am J Respir Crit Care Med 181:825-31. 2010..However, interruption of CPAP therapy is common and is associated with a decline in daytime function...
- Modafinil improves daytime sleepiness in patients with mild to moderate obstructive sleep apnoea not using standard treatments: a randomised placebo-controlled crossover trialJulia L Chapman
The NHMRC Centre for Integrated Research and Understanding of Sleep CIRUS, The University of Sydney, Sydney, New South Wales, Australia
Thorax 69:274-9. 2014..Modafinil is a wake-promoting drug licensed to treat residual sleepiness in CPAP-treated OSA. We hypothesised that modafinil may effectively treat sleepiness in untreated mild to moderate OSA...